Form 8-K - Current report:
SEC Accession No. 0001104659-23-097802
Filing Date
2023-09-01
Accepted
2023-09-01 16:46:45
Documents
14
Period of Report
2023-08-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2325384d1_8k.htm   iXBRL 8-K 29309
2 EXHIBIT 10.2 tm2325384d1_ex10-2.htm EX-10.2 26642
3 EXHIBIT 10.3 tm2325384d1_ex10-3.htm EX-10.3 36924
  Complete submission text file 0001104659-23-097802.txt   283116

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nnvc-20230829.xsd EX-101.SCH 3030
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nnvc-20230829_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nnvc-20230829_pre.xml EX-101.PRE 22369
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2325384d1_8k_htm.xml XML 3173
Mailing Address 1 CONTROLS DRIVE SHELTON CT 06484
Business Address 1 CONTROLS DRIVE SHELTON CT 06484 (203) 937-6137
NANOVIRICIDES, INC. (Filer) CIK: 0001379006 (see all company filings)

EIN.: 760674577 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36081 | Film No.: 231233160
SIC: 2834 Pharmaceutical Preparations